Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.

Kevin L WinthropMichael E WeinblattJoan BathonGerd R BurmesterPhillip J MeaseLeslie CroffordVivian BykerkMaxime DougadosJames Todd RosenbaumXavier MarietteJoachim SieperFritz MelchersBruce N CronsteinFerry C BreedveldJoachim KaldenJosef S SmolenDaniel Furst

Published in: Annals of the rheumatic diseases (2019)

Unmet needs for new therapies and trial designs, particularly for those with treatment refractory disease, remain a top priority in rheumatology.

Keyphrases

juvenile idiopathic arthritis
clinical trial
study protocol
phase ii
randomized controlled trial
rheumatoid arthritis
combination therapy
systemic lupus erythematosus
double blind
electronic health record